Annual Current Liabilities
$1.82 M
-$318.90 K-14.90%
30 September 2023
Summary:
Edesa Biotech annual total current liabilities is currently $1.82 million, with the most recent change of -$318.90 thousand (-14.90%) on 30 September 2023. During the last 3 years, it has risen by +$363.20 thousand (+24.90%). EDSA annual current liabilities is now -52.97% below its all-time high of $3.87 million, reached on 31 August 2013.EDSA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$2.36 M
+$209.90 K+9.76%
30 June 2024
Summary:
Edesa Biotech quarterly total current liabilities is currently $2.36 million, with the most recent change of +$209.90 thousand (+9.76%) on 30 June 2024. Over the past year, it has increased by +$538.70 thousand (+29.57%). EDSA quarterly current liabilities is now -58.27% below its all-time high of $5.66 million, reached on 30 June 2022.EDSA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDSA Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +29.6% |
| 3 y3 years | +24.9% | +61.8% |
| 5 y5 years | +294.7% | - |
EDSA Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.9% | +24.9% | -58.3% | +84.4% |
| 5 y | 5 years | -14.9% | +294.7% | -58.3% | +307.8% |
| alltime | all time | -53.0% | -58.3% |
Edesa Biotech Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $2.36 M(+9.8%) |
| Mar 2024 | - | $2.15 M(+8.2%) |
| Dec 2023 | - | $1.99 M(+9.1%) |
| Sept 2023 | $1.82 M(-14.9%) | $1.82 M(+19.2%) |
| June 2023 | - | $1.53 M(-2.3%) |
| Mar 2023 | - | $1.56 M(+22.2%) |
| Dec 2022 | - | $1.28 M(-40.2%) |
| Sept 2022 | $2.14 M(+46.8%) | $2.14 M(-62.2%) |
| June 2022 | - | $5.66 M(+69.6%) |
| Mar 2022 | - | $3.34 M(+90.9%) |
| Dec 2021 | - | $1.75 M(+19.8%) |
| Sept 2021 | $1.46 M(-4.7%) | $1.46 M(+48.3%) |
| June 2021 | - | $983.50 K(-78.7%) |
| Mar 2021 | - | $4.62 M(+409.8%) |
| Dec 2020 | - | $906.30 K(-40.8%) |
| Sept 2020 | $1.53 M(+231.4%) | $1.53 M(+55.6%) |
| June 2020 | - | $983.10 K(+69.8%) |
| Mar 2020 | - | $578.90 K(-17.8%) |
| Dec 2019 | - | $704.20 K(-30.6%) |
| Sept 2019 | $461.60 K(-6.4%) | - |
| June 2019 | - | $1.01 M(+15.2%) |
| Mar 2019 | - | $881.40 K(+48.9%) |
| Dec 2018 | - | $592.00 K(+20.0%) |
| Sept 2018 | $493.40 K(+53.8%) | $493.40 K(+19.0%) |
| June 2018 | - | $414.60 K(-29.7%) |
| Mar 2018 | - | $589.80 K(+2.7%) |
| Dec 2017 | - | $574.40 K(+79.0%) |
| Sept 2017 | $320.90 K(-48.5%) | $320.90 K(-24.5%) |
| June 2017 | - | $425.30 K(-1.9%) |
| Mar 2017 | - | $433.40 K(-28.0%) |
| Dec 2016 | - | $602.10 K(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2016 | $623.60 K(-73.8%) | $623.60 K(-25.7%) |
| June 2016 | - | $839.00 K(+36.2%) |
| Mar 2016 | - | $616.10 K(-14.9%) |
| Dec 2015 | - | $723.70 K(-69.6%) |
| Sept 2015 | $2.38 M(+254.2%) | $2.38 M(+33.7%) |
| June 2015 | - | $1.78 M(-38.7%) |
| Mar 2015 | - | $2.90 M(-26.6%) |
| Dec 2014 | - | $3.96 M(+178.4%) |
| Sept 2014 | $672.20 K(-52.7%) | - |
| Aug 2014 | $1.42 M(-63.3%) | $1.42 M(+39.1%) |
| May 2014 | - | $1.02 M(-42.0%) |
| Feb 2014 | - | $1.76 M(-2.4%) |
| Nov 2013 | - | $1.81 M(-53.4%) |
| Aug 2013 | $3.87 M(+589.2%) | $3.87 M(+1041.8%) |
| May 2013 | - | $339.30 K(-23.7%) |
| Feb 2013 | - | $444.80 K(-21.0%) |
| Nov 2012 | - | $562.80 K(+0.1%) |
| Aug 2012 | $562.10 K(+253.3%) | $562.10 K(+52.8%) |
| May 2012 | - | $367.80 K(+18.5%) |
| Feb 2012 | - | $310.50 K(-39.8%) |
| Nov 2011 | - | $516.20 K(+224.5%) |
| Aug 2011 | $159.10 K(-62.2%) | $159.10 K(+20.1%) |
| May 2011 | - | $132.50 K(-1.1%) |
| Feb 2011 | - | $134.00 K(-71.2%) |
| Nov 2010 | - | $464.90 K(+10.5%) |
| Aug 2010 | $420.60 K(>+9900.0%) | $420.60 K(+268.9%) |
| May 2010 | - | $114.00 K(+125.7%) |
| Jan 2010 | - | $50.50 K(+268.6%) |
| Oct 2009 | - | $13.70 K(>+9900.0%) |
| Apr 2009 | $0.00(-100.0%) | $0.00 |
| Apr 2008 | $9400.00 | - |
FAQ
- What is Edesa Biotech annual total current liabilities?
- What is the all time high annual current liabilities for Edesa Biotech?
- What is Edesa Biotech quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Edesa Biotech?
- What is Edesa Biotech quarterly current liabilities year-on-year change?
What is Edesa Biotech annual total current liabilities?
The current annual current liabilities of EDSA is $1.82 M
What is the all time high annual current liabilities for Edesa Biotech?
Edesa Biotech all-time high annual total current liabilities is $3.87 M
What is Edesa Biotech quarterly total current liabilities?
The current quarterly current liabilities of EDSA is $2.36 M
What is the all time high quarterly current liabilities for Edesa Biotech?
Edesa Biotech all-time high quarterly total current liabilities is $5.66 M
What is Edesa Biotech quarterly current liabilities year-on-year change?
Over the past year, EDSA quarterly total current liabilities has changed by +$538.70 K (+29.57%)